Author response to "Absence of proximal muscle weakness, dysarthria, and facial diplegia suggest Guillain–Barre syndrome rather than CIDP"-Reference-Cited by-同舟云学术

Author response to "Absence of proximal muscle weakness, dysarthria, and facial diplegia suggest Guillain–Barre syndrome rather than CIDP"

Published:2023-06-29 Issue:1 Volume:59 Page:
ISSN:1687-8329
Container-title:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
language:en
Short-container-title:Egypt J Neurol Psychiatry Neurosurg

Author:

Tsiptsios Dimitrios^ORCID,Fotiadou Aggeliki,Karatzetzou Stella,Kitmeridou Sofia,Iliopoulos Ioannis

Abstract

AbstractIn many instances, the differential diagnosis between Guillain–Barre syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP) may be challenging. The aim of this letter to the editor is to elucidate comments and concerns raised, regarding our latest published article dealing with two patients that developed acute-onset CIDP after SARS-CoV-2 infection and Ad26.COV2.S vaccination, respectively.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),General Neuroscience,Pshychiatric Mental Health,Surgery

Link

https://link.springer.com/content/pdf/10.1186/s41983-023-00689-5.pdf

Reference12 articles.

1. Finsterer J. Absence of proximal muscle weakness, dysarthria, and facial diplegia suggests Guillain-Barre syndrome rather than CIDP. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):161. https://doi.org/10.1186/s41983-022-00598-z.

2. Fotiadou A, Tsiptsios D, Karatzetzou S, Kitmeridou S, Iliopoulos J. Acute onset chronic inflammatory demyelinating polyneuropathy complicating SARS-CoV-2 infection and Ad26.COV2.S vaccination: report of two cases. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):116. https://doi.org/10.1186/s41983-022-00515-4.

3. Ruts L, Drenthen J, Jacobs BC, van Doorn PA, Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain–Barre syndrome: a prospective study. Neurology. 2010;74(21):1680–6. https://doi.org/10.1212/WNL.0b013e3181e07d14.

4. Bagella CF, Corda DG, Zara P, Elia AE, Ruiu E, Sechi E, Solla P. Chronic inflammatory demyelinating polyneuropathy after ChAdOx1 nCoV-19 vaccination. Vaccines (Basel). 2021;9(12):1502. https://doi.org/10.3390/vaccines9121502.

5. de Souza A, Oo WM, Giri P. Inflammatory demyelinating polyneuropathy after the 226 ChAdOx1 nCoV-19 vaccine may follow a chronic course. J Neurol Sci. 2022;436: 120231.